Titrating lovaza from 4 to 8 to 12 grams/day in patients with primary hypertriglyceridemia who had triglyceride levels >500 mg/dl despite conventional triglyceride lowering therapy

Eicosapentaenoic Acid Ethyl Ester (AMR101) Therapy in Patients With Very High Triglyceride Levels (from the Multi-center, plAcebo-controlled, Randomized, double-blINd, 12-week study with an open-label Extension [MARINE] Trial)

(2011) Harold E. Bays et al.   AMERICAN JOURNAL OF CARDIOLOGY

Novel developments in omega-3 fatty acid-based strategies

(2011) Michael H. Davidson et al.   CURRENT OPINION IN LIPIDOLOGY

Independent and Combined Effects of Exercise Training and Metformin on Insulin Sensitivity in Individuals With Prediabetes

(2011) S. K. Malin et al.   DIABETES CARE

All-cause and cardiovascular mortality in treated patients with severe hypertriglyceridaemia: A long-term prospective registry study

(2010) H.A.W. Neil et al.   ATHEROSCLEROSIS

Novel drugs in familial combined hyperlipidemia: lessons from type 2 diabetes mellitus

(2010) Martijn CGJ Brouwers et al.   CURRENT OPINION IN LIPIDOLOGY

Extended-release niacin decreases serum fetuin-A concentrations in individuals with metabolic syndrome

(2009) Shalini V. Kaushik et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Prescription Omega-3-Acid Ethyl Esters for the Treatment of Very High Triglycerides

(2009) Richard Sadovsky et al.   POSTGRADUATE MEDICINE

Effectiveness of Combined Statin Plus Omega-3 Fatty Acid Therapy for Mixed Dyslipidemia

(2008) Philip Barter et al.   AMERICAN JOURNAL OF CARDIOLOGY